These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

825 related articles for article (PubMed ID: 32311490)

  • 1. Targeting DUSP7 signaling alleviates hepatic steatosis, inflammation and oxidative stress in high fat diet (HFD)-fed mice via suppression of TAK1.
    Wu L; Liu Y; Zhao Y; Li M; Guo L
    Free Radic Biol Med; 2020 Jun; 153():140-158. PubMed ID: 32311490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting DUSP16/TAK1 signaling alleviates hepatic dyslipidemia and inflammation in high fat diet (HFD)-challenged mice through suppressing JNK MAPK.
    Wu YK; Hu LF; Lou DS; Wang BC; Tan J
    Biochem Biophys Res Commun; 2020 Mar; 524(1):142-149. PubMed ID: 31982140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liensinine alleviates high fat diet (HFD)-induced non-alcoholic fatty liver disease (NAFLD) through suppressing oxidative stress and inflammation via regulating TAK1/AMPK signaling.
    Liang L; Ye S; Jiang R; Zhou X; Zhou J; Meng S
    Int Immunopharmacol; 2022 Mar; 104():108306. PubMed ID: 34999396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARM1 deletion restrains NAFLD induced by high fat diet (HFD) through reducing inflammation, oxidative stress and lipid accumulation.
    Pan ZG; An XS
    Biochem Biophys Res Commun; 2018 Apr; 498(3):416-423. PubMed ID: 29454967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of Vsig4 attenuates macrophage-mediated hepatic inflammation and fibrosis in high fat diet (HFD)-induced mice.
    Li Y; Sun JP; Wang J; Lu WH; Xie LY; Lv J; Li HX; Yang SF
    Biochem Biophys Res Commun; 2019 Aug; 516(3):858-865. PubMed ID: 31266632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppressing NLRP2 expression accelerates hepatic steatosis: A mechanism involving inflammation and oxidative stress.
    Li C; Liu Q; Xie L
    Biochem Biophys Res Commun; 2018 Dec; 507(1-4):22-29. PubMed ID: 30454891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. JIP3 knockout protects mice against high fat diet-induced liver injury.
    Ma XJ; Xing HZ; Ren GF; Rao XJ; Li ZZ
    Biochem Biophys Res Commun; 2018 Mar; 497(3):819-826. PubMed ID: 29454969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of RIP3 initiates annihilation of high-fat diet initialized nonalcoholic hepatosteatosis: A mechanism involving Toll-like receptor 4 and oxidative stress.
    Chenxu G; Minxuan X; Yuting Q; Tingting G; Jing F; Jinxiao L; Sujun W; Yongjie M; Deshuai L; Qiang L; Linfeng H; Xuyuan N; Mingxing W; Ping H; Jun T
    Free Radic Biol Med; 2019 Apr; 134():23-41. PubMed ID: 30599260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secreted modular calcium-binding protein 2 promotes high fat diet (HFD)-induced hepatic steatosis through enhancing lipid deposition, fibrosis and inflammation via targeting TGF-β1.
    Yuting Y; Lifeng F; Qiwei H
    Biochem Biophys Res Commun; 2019 Jan; 509(1):48-55. PubMed ID: 30581002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ubiquitin-Specific Peptidase 10 (USP10) Inhibits Hepatic Steatosis, Insulin Resistance, and Inflammation Through Sirt6.
    Luo P; Qin C; Zhu L; Fang C; Zhang Y; Zhang H; Pei F; Tian S; Zhu XY; Gong J; Mao Q; Xiao C; Su Y; Zheng H; Xu T; Lu J; Zhang J
    Hepatology; 2018 Nov; 68(5):1786-1803. PubMed ID: 29698567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term subcutaneous injection of lipopolysaccharides and high-fat diet induced non-alcoholic fatty liver disease through IKKε/ NF-κB signaling.
    He Q; Zeng J; Yao K; Wang W; Wu Q; Tang R; Xia X; Zou X
    Biochem Biophys Res Commun; 2020 Nov; 532(3):362-369. PubMed ID: 32883523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of XIAP on high fat diet-induced hepatic steatosis: a mechanism involving NLRP3 inflammasome and oxidative stress.
    Zilu S; Qian H; Haibin W; Chenxu G; Deshuai L; Qiang L; Linfeng H; Jun T; Minxuan X
    Aging (Albany NY); 2019 Dec; 11(24):12177-12201. PubMed ID: 31841118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual-Specificity Phosphatase 26 Protects Against Nonalcoholic Fatty Liver Disease in Mice Through Transforming Growth Factor Beta-Activated Kinase 1 Suppression.
    Ye P; Liu J; Xu W; Liu D; Ding X; Le S; Zhang H; Chen S; Chen M; Xia J
    Hepatology; 2019 May; 69(5):1946-1964. PubMed ID: 30582764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of NF-κB activation by PDLIM2 restrains hepatic lipogenesis and inflammation in high fat diet induced mice.
    Hao YR; Tang FJ; Zhang X; Wang H
    Biochem Biophys Res Commun; 2018 Sep; 503(2):564-571. PubMed ID: 29852170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HPS protects the liver against steatosis, cell death, inflammation, and fibrosis in mice with steatohepatitis.
    Yang Y; Liu X; Chen H; Wang P; Yao S; Zhou B; Yin R; Li C; Wu C; Yang X; Yu M
    FEBS J; 2022 Sep; 289(17):5279-5304. PubMed ID: 35285180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HADHA alleviates hepatic steatosis and oxidative stress in NAFLD via inactivation of the MKK3/MAPK pathway.
    Ding J; Wu L; Zhu G; Zhu J; Luo P; Li Y
    Mol Biol Rep; 2023 Feb; 50(2):961-970. PubMed ID: 36376538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intermittent restraint-induced sympathetic activation attenuates hepatic steatosis and inflammation in a high-fat diet-fed mouse model.
    Lee SB; Kim HG; Lee JS; Kim WY; Lee MM; Kim YH; Lee JO; Kim HS; Son CG
    Am J Physiol Gastrointest Liver Physiol; 2019 Dec; 317(6):G811-G823. PubMed ID: 31604029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic STAMP2 alleviates high fat diet-induced hepatic steatosis and insulin resistance.
    Kim HY; Park SY; Lee MH; Rho JH; Oh YJ; Jung HU; Yoo SH; Jeong NY; Lee HJ; Suh S; Seo SY; Cheong J; Jeong JS; Yoo YH
    J Hepatol; 2015 Aug; 63(2):477-85. PubMed ID: 25646886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor Necrosis Factor α-Induced Protein 8-Like 2 Alleviates Nonalcoholic Fatty Liver Disease Through Suppressing Transforming Growth Factor Beta-Activated Kinase 1 Activation.
    Liu Y; Song J; Yang J; Zheng J; Yang L; Gao J; Tian S; Liu Z; Meng X; Wang JC; Dai Z; Tang YD
    Hepatology; 2021 Sep; 74(3):1300-1318. PubMed ID: 33768585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Remdesivir attenuates high fat diet (HFD)-induced NAFLD by regulating hepatocyte dyslipidemia and inflammation via the suppression of STING.
    Li YN; Su Y
    Biochem Biophys Res Commun; 2020 May; 526(2):381-388. PubMed ID: 32223926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.